跳至主要内容
临床试验/NCT02410616
NCT02410616已完成不适用

European Comparative Effectiveness Research on Internet-based Depression Treatment - Swiss Trial

University of Bern4 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2015年3月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
4
主要终点
Patient Health Questionnaire-9 (PHQ-9)

研究概览

简要总结

To compare the clinical and cost-effectiveness of blended Cognitive Behavioural Therapy (CBT) for adults with major depressive disorder (MDD) with treatment as usual (TAU) in Swiss patients in secondary care

详细描述

Background

Depression is a common mental disorder with a negative impact on mental well-being, quality of life, and social and work-related functioning both in the short and longer term. Additionally, depression is associated with increased morbidity, mortality, health care utilization and health care costs. On a population level, depression is one of the most costly diseases. The economic costs of depression were estimated at €136.3 billion (EU25) in 2010 in the EU and are still rising. European health care systems face the challenge of improving access to cost-effective treatments while simultaneously working to sustain budgetary stability in times of economic austerity.

Internet-based depression treatment appears a very promising alternative to current routine depression treatment strategies. Meta-analyses have demonstrated the clinical effectiveness and potential cost-effectiveness of Internet-based treatment for depression in controlled research setting. Internet-based treatment thus has the potential to keep depression treatment affordable, as it enables mental health care providers to reach out to large populations needing depression treatment at a better cost-effectiveness than those of standard treatment as usual (TAU), but with similar levels of clinical efficacy and quality of care. The trials will be conducted in 8 European countries.

Objective

To compare the clinical and cost-effectiveness of blended CBT and TAU in secondary care

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Being 18 years of age or older
  • Meet DSM-IV diagnostic criteria for MDD confirmed by MINI International Neuropsychiatric Interview version 5.0
  • Informed Consent
  • Having access to a PC and Internet connection
  • Having a Smartphone that is compatible with the mobile component of the intervention
  • Understanding of the German language spoken and written
  • Exclusion Criteria
  • Current high risk for suicide according to the MINI Interview section C
  • Serious psychiatric co-morbidity: substance dependence, bipolar affective disorder, psychotic illness, obsessive compulsive disorder, as established at the MINI interview
  • Currently receiving psychological treatment for depression
  • Being unable to comprehend the spoken and written language (German)
  • Not having access to a PC and fast Internet connection (i.e. broadband or comparable).
  • Not having a Smartphone that is compatible with the mobile component of the intervention that is offered or not willing to carry a Smartphone during the duration of treatment

排除标准

  • 未提供

研究组 & 干预措施

Blended CBT

Experimental

Internet based blended CBT depression treatment combines individual face-to-face cognitive behavioural therapy (CBT) with CBT delivered through an Internet based treatment platform with mobile phone components. The core components of the CBT treatment are: (1) psychoeducation, (2) behavioural activation, (3) cognitive restructuring, and (4) relapse prevention.

干预措施: Blended CBT (Behavioral)

Treatment as usual

Active Comparator

Treatment as usual (TAU) is defined as the routine care that subjects receive when they are diagnosed with depression in the secondary care system. The investigators will not interfere with treatment as usual but they will monitor carefully which health care services are utilized by usual care patients using patient records and through self-report.

干预措施: Treatment as usual (Behavioral)

结局指标

主要结局

Patient Health Questionnaire-9 (PHQ-9)

时间窗: 18 weeks

次要结局

  • Assessment of Quality of Life (AQoL-6D)(Baseline, 12 weeks, 18 weeks, 6 months, and 12 months)
  • Quick Inventory of Depressive Symptomatology Self-Report (QIDS-16-SR)(Baseline, 12 weeks, 18 weeks, 6 months, and 12 months)
  • MINI International Neuropsychiatric Interview (M.I.N.I; Ackenheil et al., 1999)(Baseline, 18 weeks, and 12 months)
  • EuroQoL (EQ-5D-5L; Herdman et al., 2011)(Baseline, 12 weeks, 18 weeks, 6 months, and 12 months)
  • Questionnaires on Costs Associated with Psychiatric Illness (TiC-P; Hakkaart-van Rooijen, van Straten, Donker, Tiemens, 2002)(Baseline, 12 weeks, 18 weeks, 6 months, and 12 months)
  • Client Satisfaction Questionnaire (CSQ-8; Nguyen, Attkinson, & Stegner, 1983)(12 weeks, and 18 weeks)
  • System Usability Scale (SUS; Brooke, 1996)(12 weeks, and 18 weeks)
  • Patient Health Questionnaire-9 (PHQ-9)(Baseline, 12 weeks, 6 months, and 12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

相关资讯

E-Compared-CH: Comparative Effectiveness Research on... | 临床试验